emetine has been researched along with Prostatic Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akinboye, ES; Bakare, O; Bamji, ZD; Copeland, RL; Denmeade, SR; Ejeh, D; Kwabi-Addo, B | 1 |
| Barratt, G; Døskeland, SO; Herfindal, L; Myhren, L; Nicolas, V; Nilssen, IM | 1 |
| Akinboye, E; Bakare, O; Bamji, ZD; Copeland, RL; Kanaan, YM; Washington, KN | 1 |
| Akinboye, ES; Bakare, O; Brennen, WN; Denmeade, SR; Rosen, DM | 1 |
| Akinboye, ES; Bakare, O; Denmeade, SR; Kwabi-Addo, B; Rosen, MD | 1 |
| Allinen, M; Azorsa, DO; Basik, M; Bova, GS; Bubendorf, L; Carpten, JD; Chen, Y; Elkahloun, A; Elowe, S; Hautaniemi, S; Huusko, P; Kallioniemi, OP; Kiefer, JA; Lugli, A; Moses, T; Mousses, S; Ozcelik, H; Pawson, T; Ponciano-Jackson, D; Robbins, C; Sauter, G; Schleutker, J; Trent, JM; Tuzmen, S; Weaver, D; Wolf, M | 1 |
| Mercola, D; Welsh, J | 1 |
| Edgren, H; Huusko, P; Kallioniemi, O; Kilpinen, S; Mousses, S; Muggerud, A; Sørlie, T; Wolf, M | 1 |
| Boon-Unge, K; Govitrapong, P; Yu, Q; Zhou, A; Zhou, J; Zou, T | 1 |
| Anderson, P; Chen, S; Cho, MR; Gilks, N; Golan, DE; Kedersha, N; Li, W; Yacono, PW | 1 |
| Abd-Rabbo, H | 1 |
1 review(s) available for emetine and Prostatic Neoplasms
| Article | Year |
|---|---|
NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer.
Topics: Animals; Cell Line, Tumor; Codon, Nonsense; Emetine; Genetic Testing; Humans; Male; Mutation; Neoplasms; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Synthesis Inhibitors; Receptor, EphB2; RNA Stability; RNA, Neoplasm | 2005 |
10 other study(ies) available for emetine and Prostatic Neoplasms
| Article | Year |
|---|---|
Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.
Topics: Cell Line, Tumor; Cell Proliferation; Drug Design; Emetine; Humans; Male; Prostatic Neoplasms; Structure-Activity Relationship | 2015 |
Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.
Topics: Anthracyclines; Cell Line, Tumor; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Resistance; Emetine; Flow Cytometry; Folate Receptor 2; Humans; Leukemia, Myeloid, Acute; Light; Liposomes; Male; Methotrexate; Polyethylene Glycols; Prostatic Neoplasms; Scattering, Radiation; Tumor Suppressor Protein p53 | 2014 |
Apoptotic Effects of Novel Dithiocarbamate Analogs of Emetine in Prostate Cancer Cell Lines.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Ditiocarb; Emetine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms | 2015 |
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dipeptidyl Peptidase 4; Drug Design; Emetine; Endopeptidases; Gelatinases; Humans; Male; Membrane Proteins; Prodrugs; Prostatic Neoplasms; Serine Endopeptidases; Structure-Activity Relationship | 2016 |
Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.
Topics: Cell Line, Tumor; Drug Design; Emetine; Humans; Hydrogen-Ion Concentration; Hydrolysis; Inhibitory Concentration 50; Male; Prostatic Neoplasms | 2012 |
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Topics: Cell Line, Tumor; Codon, Nonsense; Emetine; Genes, Tumor Suppressor; Humans; Male; Molecular Sequence Data; Mutation; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Receptor, EphB2; RNA Stability; Transfection | 2004 |
From mRNA to tumor suppressor.
Topics: Emetine; Genes, Tumor Suppressor; Humans; Male; Prostatic Neoplasms; Receptor, EphB2; RNA Stability; RNA, Messenger | 2004 |
Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Topics: Alternative Splicing; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Down-Regulation; Emetine; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Marine Toxins; Okadaic Acid; Oxazoles; Prostatic Neoplasms; Protein Phosphatase 1; Protein Phosphatase 2; Up-Regulation; Uterine Cervical Neoplasms | 2007 |
Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules.
Topics: Animals; COS Cells; Cytoplasmic Granules; Emetine; Image Processing, Computer-Assisted; Male; Membrane Proteins; Microscopy, Fluorescence; Poly(A)-Binding Proteins; Polyribosomes; Prostatic Neoplasms; Protein Biosynthesis; Proteins; Puromycin; RNA-Binding Proteins; RNA, Messenger, Stored; Stress, Physiological; Tumor Cells, Cultured | 2000 |
Chemotherapy of neoplasia (cancer) with dehydroemetine.
Topics: Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Child; Child, Preschool; Emetine; Esophageal Neoplasms; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tongue Neoplasms; Urinary Bladder Neoplasms | 1969 |